PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS AMENDMENT NO. 1Purchase and Sale Agreement • February 25th, 2014 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
This Purchase and Sale Agreement and Joint Escrow Instructions Amendment No. 1 (the “Amendment No.1”) is made as of October 30, 2012 (the “Effective Date”) by and between Electronics For Imaging, Inc., a Delaware corporation (“Seller”), and Gilead Sciences, Inc., a Delaware corporation (“Buyer”), in the following factual context:
THIRD AMENDMENT (“Amendment No. 3”)Development and Licensing Agreement • February 25th, 2014 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • California
effective as of October 5, 2012 (“Amendment No. 3 Effective Date”) to the DEVELOPMENT AND LICENSING AGREEMENT dated as of September 27, 1996, as amended and supplemented by the FIRST AMENDMENT AND SUPPLEMENT effective as of November 15, 2005 and as amended by the SECOND AMENDMENT effective as of December 22, 2011 (the “Agreement”) by and between GILEAD SCIENCES, INC., a Delaware Corporation (“Gilead”), on the one hand, and F. HOFFMANN-LA ROCHE LTD, a corporation organized under the laws of Switzerland, and HOFFMANN-LA ROCHE INC., a corporation organized under the laws of New Jersey, on the other hand (collectively “Roche”). Capitalized terms used but not defined herein shall have the meanings assigned them in the Agreement.
Memorandum on the Patent Litigation Committee Effective Date: October 10, 2013Memorandum on the Patent Litigation Committee • February 25th, 2014 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
